A framework to integrate AI into clinical practice.
Establishing a new benchmark for stroke triage, comparative research reveals critical performance gaps and validates Aidoc’s platform as the superior choice
Aidoc, the leading clinical AI platform, today announced the presentation of two new scientific abstracts comparing AI-powered stroke solutions at the International Stroke Conference (ISC) 2026. The data, presented by independent academic institutions, highlights the real-world reliability of Aidoc’s neuro AI algorithms and demonstrates a significant performance advantage over other market solutions, particularly in the triage of medium vessel occlusions (MeVOs).
As health systems increasingly rely on AI to expedite time-sensitive critical cases, these invaluable tools demand rigorous performance evaluation. These new findings presented at ISC highlight significant clinical value gaps between available AI solutions, specifically regarding sensitivity and the device’s anatomical coverage.
A comparative study conducted by The University of Texas Medical Branch evaluated the performance of Aidoc against a conventional AI vendor in a clinical setting.1 The study compared the triage accuracy of both systems across 1,557 consecutive CTA exams.
The results revealed a distinct performance gap, particularly in the flagging of MeVOs, which are often more difficult to identify but critical for patient outcomes:
In a separate study presented by Saint Louis University School of Medicine, researchers analyzed 1,000 CTA exams to evaluate the effectiveness of Aidoc’s VO algorithm in a “messy” real-world environment.2 The study demonstrated that high fidelity performance supports AI integration into workflows for evaluating both anterior and posterior circulation occlusions.
“These findings illuminate a crucial distinction in the market: simply having an algorithm isn’t the same as delivering clinical-grade performance,” said Elad Walach, co-founder and CEO of Aidoc. “When we see a 75% gap in sensitivity for identifying MeVOs, it underscores that high-fidelity AI is a necessity for ensuring that the complete spectrum of complex, time-sensitive cases are flagged for immediate review.”
Aidoc will be at Booth #601 throughout ISC 2026 showcasing its Full Brain AI Solution.
Citations
Aidoc experts, customers and industry leaders share the latest in AI benefits and adoption.
Explore how clinical AI can transform your health system with insights rooted in real-world experiences.
Learn how to go beyond the algorithm to develop a scalable AI strategy and implementation plan.
Explore how Aidoc can help increase hospital efficiency, improve outcomes and demonstrate ROI.